CNL Team Recognized With CNIC 2024 Ecosystem Innovation Award for Production of Promising New Medical Isotope

CNL recognized for producing Canada's first Actinium-225 for cancer treatment

CHALK RIVER — Canadian Nuclear Laboratories (CNL) has been recognized by the Canadian Nuclear Isotope Council (CNIC) alongside the Sylvia Fedoruk Centre and Advanced Cyclotron Systems Inc. for being the first in Canada to produce Actinium-225, a promising new medical isotope in the fight against cancer, using a cyclotron and Radium-226 targets. The team was honoured with this year’s CNIC Ecosystem Innovation Award at the annual awards ceremony h…

CNL Team Recognized With CNIC 2024 Ecosystem Innovation Award for Production of Promising New Medical Isotope

CHALK RIVER, Ontario, May 06, 2025 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that it has been recognized by the Canadian Nuclear Isotope Council (CNIC) alongside the Sylvia Fedoruk…

CNL Team Recognized With CNIC 2024 Ecosystem Innovation Award for Production of Promising New Medical Isotope - Today's Northumberland - Your Source For What's Happening Locally and Beyond

Canadian Nuclear Isotope Council honours CNL, Sylvia Fedoruk Centre and Advanced Cyclotron Systems for first cyclotron irradiation of Radium-226 to produce Actinium-225 in Canada Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that it has been recognized by the Canadian Nuclear Isotope Council (CNIC) alongside the Sylvia Fedoruk Centre and Advanced Cyclotron Systems Inc. f…